Actively Recruiting

Age: 6Years - 99Years
All Genders
NCT04698421

Collection of Biological Samples From Patients With Rare Neurological Diseases

Led by University Hospital, Toulouse · Updated on 2026-03-19

1000

Participants Needed

1

Research Sites

516 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The aim of this project is to improve biological collections of patients presenting rare neurological disorders with known or suspected autoimmune origin. This collection will provide appropriate biological samples to identify new biomarkers and to be accessible to the medical, scientific and industrial communities for the identification of new therapeutic strategies.

CONDITIONS

Official Title

Collection of Biological Samples From Patients With Rare Neurological Diseases

Who Can Participate

Age: 6Years - 99Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Patients of any age with neurological disorders that have known or probable autoimmune causes, including children and adults with symptoms affecting the central and/or peripheral nervous system
  • Up-to-date social health coverage
Not Eligible

You will not qualify if you...

  • Patients with neurological damage where an autoimmune cause can be ruled out
  • Known anemia with hemoglobin below 10 g/dL
  • Patients under protective supervision such as guardianship or curatorship
  • Pregnant or breastfeeding women

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Purpan University Hospital

Toulouse, France, 31059

Actively Recruiting

Loading map...

Research Team

C

Chloé Bost, PharmD, PhD

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here